FIELD MEDICAL ANNOUNCES FIRST-IN-HUMAN DATA FOR FOCAL PFA IN SCAR-RELATED VT AT HEART RHYTHM 2025
Eight presentations, including late-breaking science, live cases, and a landmark symposium CARDIFF-BY-THE-SEA, Calif., April 23, 2025 /PRNewswire/ -- Field Medical Inc., a leader in cardiac pulsed field ablation (PFA) technology, announced today its FieldForce™ Ablation System will be featured in eight scientific presentations at the 46th annual Heart Rhythm Society (HRS)...
Sustainable Period Care in Australia: Why Women Are Switching to Menstrual Discs in 2025
More Aussie women are ditching disposable pads and tampons in 2025 – here's why reusable menstrual discs like my mimi are leading the sustainable switch. MELBOURNE, Australia, April 24, 2025 /PRNewswire/ -- As conversations around sustainability and wellness continue to grow, Australian women are rethinking their period care in Australia, and many are making the switch to menstrual discs....
GenFleet Receives FDA Approval for Phase II Study of RIPK1 Inhibitor (GFH312)
SHANGHAI, Aug. 18, 2022 /PRNewswire/ -- GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has approved the clinical trial application for GFH312 in a randomized, double-blinded, placebo-controlled phase II monotherapy study. The trial will be conducted in patients with peripheral artery disease and with intermittent claudication at...
MEDICA 2022 Newcomer: Scivita Medical celebrates trade show success and the strategy of “globalization”
DUSSELDORF, Germany, Nov. 21, 2022 /PRNewswire/ -- Medical technology company Scivita Medical Technology Co., Ltd. ("Scivita Medical") looks back on an exciting week at the trade fair. Scivita Medical was able to announce a strategic cooperation with FUJIFILM Europe B.V. ("Fujifilm") at this year's MEDICA, in addition to presenting their innovative endoscopes and medical imaging technology. Under a supply...
Pharming announces the first commercial shipments of Joenja® (leniolisib) to patients in the U.S.
LEIDEN, Netherlands, April 11, 2023 /PRNewswire/ -- Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM) (Nasdaq: PHAR) announces the first commercial shipments of Joenja® (leniolisib) to patients in the United States. Joenja®, an oral, selective PI3Kδ inhibitor, is the first and only treatment approved in the U.S. for activated phosphoinositide 3-kinase delta (PI3Kδ)...
Gannex Announces China NMPA Approved Phase II and III Protocols of ASC42, an FXR Agonist, for Treatment of Primary Biliary Cholangitis
SHANGHAI, Nov. 15, 2021 /PRNewswire/ -- Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. (HKEX:1672) announces today that the protocols of Phase II and III clinical trials of ASC42 to treat patients with primary biliary cholangitis (PBC) has been approved by China National Medical Products Administration (NMPA). PBC is a new chronic hepatobiliary disease indication...
AnPac Bio-Medical Science Enters into Definitive Agreement to Make Another Acquisition to Significantly Expand Scope of Business in the U.S.
NEW YORK, Feb. 13, 2023 /PRNewswire/ -- AnPac Bio-Medical Science Co., Ltd. (the "Company") (NASDAQ: ANPC), a company with operations in the United States and China announced that on February 12, 2023, the Company, through its subsidiary Foodbase Group Inc., entered into a definitive equity purchase agreement to acquire a group of affiliated companies, SLV Windfall Group LLC, Windfall...
ThinkCyte Unveils MorphoScan Cloud: A Versatile Cloud-Based Platform for AI-Driven Cell Morphology Data Analysis
TOKYO, June 3, 2025 /PRNewswire/ -- ThinkCyte, a life science company pioneering advanced AI-powered cell analysis and sorting technologies, today announced the pre-commercial launch of MorphoScan Cloud, its new cloud-based platform designed for flexible data access, faster processing, and advanced AI–driven analysis. The launch coincides with the 38th Annual Congress...
PillWork’s Upcoming Launch and its Landmark Partnership with Precision Nutrition Association
SEOUL, South Korea, Nov. 6, 2023 /PRNewswire/ -- With much anticipation surrounding its impending release, PillWork officially announces its launch scheduled for the end of 2023. An integral part of this excitement is the company's crucial alliance with the esteemed Precision Nutrition Association. This Association champions a merger of medical science with the latest in IT, envisioning healthcare extending beyond...
Seegene Opens New Subsidiary in Bogotá, Colombia, to Advance Regional COVID-19 Testing
SEOUL, South Korea, Nov. 15, 2021 /PRNewswire/ -- Seegene Inc. (KQ 096530), a leading biotechnology firm specializing in molecular diagnostics (MDx), has announced the opening of an eighth global subsidiary, strategically located in Bogotá, Colombia. The new entity, known as 'Seegene Colombia S.A.S,' began operations in mid-October. While the immediate need...
